Genius Sports
GENI
6.34
+0.12
+1.93%
Genius Sports
US · GENI
#2921 by market cap
Listed 1970
6.34
+0.12
+1.93%
Live - 5344 symbols - heartbeat 78s ago
· 2026-10-08 08:40
Pre-market
6.40
+0.95%
After-hours
6.31
-0.47%
Overnight
6.41
+1.10%
- Market cap
- 1.70B
- P/E (TTM)i
- -9.46
- P/Bi
- 2.48
- EPSi
- -0.44
- Div yieldi
- 0.00%
- 52W posi
- 29%
Reader sentiment
Are you bullish or bearish on GENI?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
Distributing
- Total institutional ownership fell 1.3 percentage points.
Institutional ownership
- Held by institutions
- 91.82% -1.28pp
- Institutions
- 326
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
AlignedInstitutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Mutual Fund56.08%
Hedge Fund27.72%
Individual/Insider8.45%
Public Company3.30%
Family Office/Trust1.87%
Sovereign Wealth Fund1.28%
Private Company0.95%
Insurance Company0.56%
Top holders as of 2026-06-30
BlackRock
7.39% · 19.77M sh
Mark Locke
7.24% · 19.38M sh
Senvest Management, LLC
5.93% · 15.88M sh
Glenview Capital Management, LLC
5.04% · 13.50M sh
Hood River Capital Management LLC
4.83% · 12.93M sh
Stephens Investment Management Group, LLC
4.00% · 10.69M sh
Shapiro Capital Management LLC
3.69% · 9.89M sh
Frontier Capital Management
3.52% · 9.43M sh
Discovery Capital Management, LLC
2.70% · 7.23M sh
Portolan Capital Management, LLC
2.63% · 7.03M sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 5 buys · 27 sells
| Name | Role | Stake |
|---|---|---|
| Mark Locke | Chief Executive Officer | 7.24% |
| Jack Davison | Chief Commercial Officer | 0.76% |
| Thomas Russell | Chief Legal Officer | 0.18% |
| Nicholas Taylor | Chief Financial Officer | 0.09% |
| Daniel Burns | Director | 0.06% |
| Kenneth Kay | Independent Director | 0.05% |
| Kimberly Williams-Bradley | Independent Director | 0.03% |
| Robert Bach | Independent Director | 0.02% |
| Claire Valoti | Independent Director | 0.01% |
| Bertrand Castellani | -- | 0.00% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-10-01 | Bertrand Castellani | -- | Derivative Exercise and Sale | -53,297 | $5.68 |
| 2026-10-01 | Bertrand Castellani | -- | Derivative Exercise and Retained | +98,474 | -- |
| 2026-09-16 | Mark Locke | Chief Executive Officer | Open Market Disposition | -800,000 | $6.54–6.58 |
| 2026-09-16 | Thomas Russell | Chief Legal Officer | Open Market Disposition | -50,000 | $6.51 |
| 2026-09-14 | Mark Locke | Chief Executive Officer | Open Market Derivative Acquisiti | +1 | $5.00 |
| 2026-09-14 | Mark Locke | Chief Executive Officer | Open Market Derivative Dispositi | -1 | $10.20 |
| 2026-03-19 | Mark Locke | Chief Executive Officer | Derivative Exercise and Sale | -7,800 | $4.53 |
| 2026-03-19 | Mark Locke | Chief Executive Officer | Derivative Exercise and Retained | +112,200 | -- |
| 2026-03-19 | Jack Davison | Chief Commercial Officer | Derivative Exercise and Sale | -35,250 | $4.53 |
| 2026-03-19 | Jack Davison | Chief Commercial Officer | Derivative Exercise and Retained | +39,750 | -- |
| 2026-03-19 | Thomas Russell | Chief Legal Officer | Derivative Exercise and Sale | -16,450 | $4.53 |
| 2026-03-19 | Thomas Russell | Chief Legal Officer | Derivative Exercise and Retained | +18,550 | -- |
| 2026-03-17 | Kenneth Kay | Independent Director | Initial Statement of Beneficial | 0 | -- |
| 2026-03-17 | Robert Bach | Independent Director | Initial Statement of Beneficial | 0 | -- |
| 2026-03-17 | Mark Locke | Chief Executive Officer | Initial Statement of Beneficial | 0 | -- |
| 2026-03-17 | Claire Valoti | Independent Director | Initial Statement of Beneficial | 0 | -- |
| 2026-03-17 | Bertrand Castellani | -- | Initial Statement of Beneficial | 0 | -- |
| 2026-03-17 | Daniel Burns | Director | Initial Statement of Beneficial | 0 | -- |
| 2026-03-17 | Jack Davison | Chief Commercial Officer | Initial Statement of Beneficial | 0 | -- |
| 2026-03-17 | Thomas Russell | Chief Legal Officer | Initial Statement of Beneficial | 0 | -- |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-08 08:40:24 · For reference only, not investment advice and not tailored to your situation.